KPMG serves as adviser to startsups during their growth phase, with the primary focus being on optimising their financial management and corporate structure. Blusense Diagnostics is a startup founded in 2014 and operating out of Denmark. Until 2020, Blusense's focus was on developing equipment to fight the Dengue virus, but when the COVID-19 pandemic broke out, the company succeeded in transforming its technology to detect Corona antibodies.
Read more about our services
Subscribe to our KPMG insights newsletter
Turn insight into opportunity with unique perspectives and actionable insights addressing the burning issues atop the C-suite agenda. We cover everything from ESG and new technologies to transactions and financial services.